[Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
D001766:Blindness / Q000188:drug therapy; D002056:Burns / Q000188:drug therapy; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003930:Diabetic Retinopathy / Q000188:drug therapy; D004336:Drug Antagonism; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012431:Rutin / Q000031:analogs & derivatives*; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D003278:Contraceptives, Oral, Hormonal; D006896:Hydroxyethylrutoside; D012431:Rutin; C005865:troxerutin
Venoruton - nicht nur bei Venopathien indiziert? Symposium über O-(beta-Hydroxyethyl)-rutoside (= Venoruton) bei Gefässerkrankungen.